OpenAI researcher Miles Wang is in talks to raise $200 million for an AI drug startup at $2 billion valuation, though he...

OpenAI researcher Miles Wang is in talks to raise $200 million for an AI drug startup at $2 billion valuation, though he disputes those figures. The undefined terms signal investor appetite for AI drug discovery outpaces clarity on business models and clinical viability. https://www.implicator.ai/openais-miles-wang-holds-200m-ai-drug-startup-talks/ #AI #DrugDiscovery #Biotech

Read Original

Related